Volume 13, Number 9—September 2007
Letter
Extensively Drug-Resistant Mycobacterium tuberculosis, India
Rajesh Mondal* and Amita Jain*
Table
Resistance pattern of XDR TB isolates*
| Strain no. | Resistant to first-line drugs | Resistant to second-line drugs |
|---|---|---|
| RM 55 | S, H, R, E | K, O, CAP, CLA, PAS, ETH |
| RM 490 | S, H, R, E | K, O, CAP, CLA, PAS, ETH |
| RM 552 | S, H, R, E | K, O, CAP, CLA, PAS, ETH |
| RM 585† | S, H, R, E | K, O, CLA, PAS, ETH |
| RM 789 | S, H, R, E | K, O, CAP, CLA, PAS, ETH |
*n = 5; XDR TB, extensively drug-resistant tuberculosis; S, streptomycin; H, isoniazid; R, rifampin; E, ethambutol; K, kanamycin; O, ofloxacin; CAP, capreomycin; CLA, clarithromycin; PAS, p– amino salicylic acid; ETH, ethionamide.
†Sensitive to capreomycin.
Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.